CIK 0001531177
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800625749
- Phone
- +1 415-889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $652,777
- in 5 filings, $653K under 10b5-1 plans
Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
- Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-04 | Badawi David Chief Technology Officer | Shares withheld for taxes | −2,431 | $12.21 | $30K | 1,485,790 |
| 2023-01-04 | Park Sam Boong Chief Operating Officer | Shares withheld for taxes | −2,393 | $12.38 | $30K | 51,424 |
| 2023-01-04 | Badawi Paul President and CEO | Shares withheld for taxes | −8,251 | $12.21 | $101K | 5,278,481 |
| 2023-01-04 | HAYDEN JEREMY B. Chief Legal Officer | Shares withheld for taxes | −1,192 | $12.38 | $15K | 1,808 |
| 2023-01-01 | Selnick Jesse Chief Financial Officer | Grant or award | +28,100 | 406,250 | ||
| 2023-01-01 | Badawi David Chief Technology Officer | Grant or award | +28,100 | 1,488,221 | ||
| 2023-01-01 | Park Sam Boong Chief Operating Officer | Grant or award | +24,100 | 53,817 | ||
| 2023-01-01 | Badawi Paul President and CEO | Grant or award | +87,800 | 5,286,732 | ||
| 2023-01-01 | HAYDEN JEREMY B. Chief Legal Officer | Grant or award | +12,000 | 3,000 | ||
| 2022-11-18 | Park Sam Boong Chief Operating Officer | Grant or award | +3,128 | $6.79 | $21K | 47,792 |
| 2022-09-21 | Badawi David Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −40,000 | 42,540 | ||
| 2022-09-21 | Badawi David Chief Technology Officer | Option exercise | +40,000 | $0.23 | $9K | 1,481,196 |
| 2022-09-21 | Badawi David Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2022-07-06 | Hicks Mack H. Director | Other disposition | −2,669,530 | 0 | ||
| 2022-07-06 | Hicks Mack H. Director | Other disposition | −1,717,140 | 0 | ||
| 2022-06-08 | Encrantz Staffan Director | Grant or award · Restricted Stock Units | +11,940 | 11,940 | ||
| 2022-06-08 | Schroeder Valeska Director | Grant or award · Restricted Stock Units | +11,940 | 11,940 | ||
| 2022-06-08 | Hicks Mack H. Director | Grant or award · Restricted Stock Units | +11,940 | 11,940 | ||
| 2022-06-08 | Zurbay Donald Director | Grant or award · Restricted Stock Units | +11,940 | 11,940 | ||
| 2022-06-08 | Rogers Erica J. Director | Grant or award · Restricted Stock Units | +11,940 | 11,940 |
Page 12 of 16 · 302 trades